Life Science Company News

Results 181 - 200 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Parkinson’s Disease at 2024 ATMRD Congress

Read more ››
By: GlobeNewswire - 20 Jun 2024

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 20 Jun 2024

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

Read more ››
By: GlobeNewswire - 20 Jun 2024

Cronos Group Announces Expansion of GrowCo to Fuel Global Growth

Read more ››
By: GlobeNewswire - 20 Jun 2024

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Read more ››
By: GlobeNewswire - 20 Jun 2024

Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector

Read more ››
By: GlobeNewswire - 20 Jun 2024

Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe

Read more ››
By: GlobeNewswire - 20 Jun 2024

Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse

Read more ››
By: GlobeNewswire - 20 Jun 2024

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS

Read more ››
By: GlobeNewswire - 20 Jun 2024

Aphaia Pharma Announces Positive Results from Phase 2 Trial Evaluating its Lead Drug Formulation for Prediabetes Treatment

Read more ››
By: GlobeNewswire - 20 Jun 2024

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia

Read more ››
By: GlobeNewswire - 20 Jun 2024

Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder

Read more ››
By: GlobeNewswire - 20 Jun 2024

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Read more ››
By: GlobeNewswire - 20 Jun 2024

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

Read more ››
By: GlobeNewswire - 20 Jun 2024

New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Family Building Benefits

Read more ››
By: GlobeNewswire - 20 Jun 2024

Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Samer Kaba, MD as Chief Medical Officer

Read more ››
By: GlobeNewswire - 20 Jun 2024

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

Read more ››
By: GlobeNewswire - 20 Jun 2024

Shineco Enters into a Letter of Intent with Meitong Technology to Address China’s Aging Population

Read more ››
By: GlobeNewswire - 20 Jun 2024

Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management

Read more ››
By: GlobeNewswire - 20 Jun 2024

Brain Canada Launches $26 Million Platform Support Grants (PSG) Program to Accelerate Neuroscience and Mental Health Research

Read more ››
By: GlobeNewswire - 20 Jun 2024
Results 181 - 200 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate